Edition:
United Kingdom

Rigel Pharmaceuticals Inc (RIGL.OQ)

RIGL.OQ on NASDAQ Stock Exchange Global Select Market

3.10USD
20 Jul 2018
Change (% chg)

$0.12 (+4.03%)
Prev Close
$2.98
Open
$2.98
Day's High
$3.12
Day's Low
$2.96
Volume
722,035
Avg. Vol
756,331
52-wk High
$4.71
52-wk Low
$2.15

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 21 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 5 5 5 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.83 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 1.59 2.58 0.70 --
Quarter Ending Dec-18 6 3.60 6.18 2.12 --
Year Ending Dec-18 6 5.19 9.10 3.10 26.42
Year Ending Dec-19 6 45.28 64.82 24.00 61.69
Earnings (per share)
Quarter Ending Sep-18 5 -0.16 -0.15 -0.17 --
Quarter Ending Dec-18 5 -0.15 -0.13 -0.17 --
Year Ending Dec-18 5 -0.64 -0.60 -0.67 -0.43
Year Ending Dec-19 5 -0.39 -0.25 -0.53 -0.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.05 0.00 0.05 100.00
Quarter Ending Dec-17 0.04 0.00 0.04 100.00
Quarter Ending Sep-17 0.00 0.90 0.90 0.00
Quarter Ending Jun-17 1.56 0.00 1.56 100.00
Quarter Ending Mar-17 3.33 3.58 0.25 7.63

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1.59 1.59 1.59 1.59 --
Quarter Ending Dec-18 3.60 3.60 3.60 3.60 --
Year Ending Dec-18 5.19 5.20 5.20 5.20 26.42
Year Ending Dec-19 45.28 45.27 45.27 45.27 61.69

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 1 0 1 0
Earnings